IL17A and neoplasm: A comparative analysis revealed a notable shift in the ratio of IFNγ+ CD8+ to IL-17A+ CD8+ T cell frequencies (Tumor- 31.2% versus 1.4%; STM- 17.3% versus 0.4%).